IL-6 is an important tumor-initiating factor in CRC, and the proliferative and survival effects of IL-6 are primarily mediated by the downstream transcription factor STAT3 36, which is the forward feedback loop of STAT3 that promotes cancer malignancy. Here, IL6 is linked to neoplasm.